4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-21-009645
President and CEO acquired 226,173 shares (grant or award)
- President and CEO acquired 26,867 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Schultz Kare · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-09 | Exercise or conversion : show line 1 in the form | +26,867 | 509,661 | D |
| 2021-02-09 | Grant or award : show line 2 in the form | +226,173 | 735,834 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-09 | Exercise or conversion : show line 3 in the form Restricted Share Units | −26,867 | 26,867 | D |
Loading xslF345X03/doc4.xml…